PPAR-γ agonists appear effective for preventing stroke recurrence

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • After stroke or transient ischemic attack (TIA), peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist therapy appears to reduce risk for recurrence and other vascular events.

Why this matters

  • Recurrent strokes represent about a third of all strokes and have hi...